Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Pogledi
• 06/15/23
0
0
Ugraditi
administrator
Pretplatnici
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari